BSX vs LYRA · P/E 20, rev $10.65B vs rev $1.5M
Boston Scientific Corp (BSX) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the BSX and LYRA stock pages for the full models.
Not investment advice.